Lexi Hazam Discusses Benicar Litigation at Mass Torts Seminar

Lexi Hazam Discusses Benicar Litigation at Mass Torts Seminar

Lieff Cabraser attorney Lexi J. Hazam will be discussing the Benicar prescription drug litigation at the 15th Anniversary of the Mass Torts Made Perfect Seminar on April 17, 2015 in Las Vegas, Nevada. Attorneys from across the nation attend the annual conference to learn from leaders of the plaintiffs’ bar of the latest developments in lawsuits involving defective and dangerous prescription drugs, medical devices, and other products that collectively have injured tens of thousands of Americans.

[Read more…]

Lexi Hazam Speaks at HarrisMartin’s MDL Conference on Benicar Prescription Drug

Lexi Hazam Speaks at HarrisMartin's MDL Conference on Benicar Prescription Drug

Lieff Cabraser attorney Lexi J. Hazam will be speaking at HarrisMartin’s MDL Conference: Xarelto, Morcellators and Emerging Torts on March 25, 2015 at The Westin San Diego. Hazam will be featured on a panel discussing the prescription drug Benicar. Hazam will also be addressing the science behind the plaintiffs’ claims.

[Read more…]

First Risperdal Trial Ends With $2.5 Million Verdict Against J&J

First Risperdal Trial Ends With $2.5 Million Verdict Against J&J

A Philadelphia jury returned a $2.5 million verdict against healthcare giant Johnson & Johnson for a 20-year-old autistic man from Alabama who allegedly developed large breasts as a teenager while prescribed the antipsychotic medication Risperdal. The lawsuit charged that Johnson & Johnson failed to warn consumers of the distressing side effects that Risperdal causes, concealing from officials the dangerous and defective risks involved when taking the prescribed medication.

[Read more…]

Prescription Drug Risperdal Linked to Abnormal Male Breast Development

Attorney Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that four young men prescribed the antipsychotic medication Risperdal recently filed separate personal injury lawsuits alleging that Risperdal is a defective and dangerous prescription drug. The complaints were brought against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the manufacturer of Risperdal, in state court in Pennsylvania, where Janssen Pharmaceuticals is located. [Read more…]

Patients Charge Benicar is a Dangerous and Defective Drug

Attorney Lexi Hazam of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that two patients prescribed olmesartan medoxomil, a widely-prescribed medication sold under the brand name Benicar, today filed a personal injury lawsuit alleging that Benicar is a dangerous and defective drug. The complaint, filed in federal court in San Francisco, names as defendants Japanese-based Daiichi Sankyo, Benicar’s manufacturer, and Forest Laboratories, which marketed Benicar in the U.S. Steven W. Teppler of the Abbott Law Group, P.A. from Jacksonville, Florida, also serves as counsel for plaintiffs. [Read more…]

Public Justice and AAJ Contest Dismissal of Big-Pharma Fraud Case

Public Justice and AAJ Contest Dismissal of Big-Pharma Fraud Case

Public Justice (represented by Lieff Cabraser) and the American Association for Justice today filed an amicus brief in the U.S. Court of Appeals for the Second Circuit urging the reinstatement of civil RICO claims that Sanofi-Aventis profited from a scheme to market and sell its antibiotic Ketek by falsely representing the drug’s safety — and concealing its risk of severe liver damage — from the FDA, doctors, and purchasers.

[Read more…]